Cargando…
Modelling mitochondrial dysfunction in Alzheimer’s disease using human induced pluripotent stem cells
Alzheimer’s disease (AD) is the most common form of dementia. To date, only five pharmacological agents have been approved by the Food and Drug Administration for clinical use in AD, all of which target the symptoms of the disease rather than the cause. Increasing our understanding of the underlying...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545525/ https://www.ncbi.nlm.nih.gov/pubmed/31171953 http://dx.doi.org/10.4252/wjsc.v11.i5.236 |